Oxaliplatin Global Buyers List: Comprehensive Guide to Importers, Distributors, and Market Insights
Oxaliplatin, a platinum-based chemotherapy medication primarily used in the treatment of colorectal cancer and other malignancies, represents a significant segment of the global oncology pharmaceutical market. As the global burden of cancer continues to rise, the demand for this essential antineoplastic agent has grown substantially, creating a complex and dynamic international trade network.
The global Oxaliplatin market was valued at approximately US$1.08–1.12 billion in 2025, with projections indicating growth to US$1.9–2.37 billion by 2031–2034 at a compound annual growth rate (CAGR) of 8.7–9.2%. This growth trajectory underscores the importance of understanding the global buyer landscape for pharmaceutical companies, distributors, and healthcare procurement professionals seeking to navigate this market effectively.
This comprehensive guide presents the Oxaliplatin global buyers list, drawing from verified customs data, trade intelligence, and market research to help stakeholders identify key importers, understand regional purchasing patterns, and make informed business decisions.
The Global Oxaliplatin Trade Landscape
India has emerged as the dominant exporter of Oxaliplatin, serving as the primary source for buyers across 123 countries worldwide. According to Indian Customs (DGFT) data, India exported US$32.6 million worth of Oxaliplatin through 3,081 shipments, with 249 active suppliers serving 693 verified buyers globally.
The HSN Code 30049049, which covers Oxaliplatin formulations, represents a significant volume of pharmaceutical trade, with 270 active importers documented in global trade databases. These buyers range from major multinational pharmaceutical corporations to regional distributors and government healthcare procurement agencies.
Top Oxaliplatin Buyers and Importers Worldwide
Leading Importers by Market Share
Based on verified customs data from Indian exports (2022–2026), the following are the top Oxaliplatin importers ranked by import value:
| Rank | Buyer Name | Country | Import Value | Market Share |
|---|---|---|---|---|
| 1 | Fresenius Kabi Deutschland GmbH | Germany | $10.0M | 21.5% |
| 2 | OOO “JODAS EXPOIM” | Russia | $3.1M | 6.7% |
| 3 | Pharmacie Centrale des Hopitaux | Algeria | $2.3M | 5.0% |
| 4 | Yusen Logistics Benelux Belgium | Belgium | $2.2M | 4.8% |
| 5 | OOOJODAS EXPOIM | Russia | $1.0M | 2.2% |
The top five buyers collectively control 40.2% of the total import value from India, reflecting a moderately concentrated buyer landscape.
Fresenius Kabi Deutschland GmbH — The Leading Global Buyer
Fresenius Kabi Deutschland GmbH (Germany) stands as the undisputed leader in Oxaliplatin procurement, accounting for 21.5% of all Indian Oxaliplatin exports. With 362 verified shipments valued at $10.0 million, this German pharmaceutical giant sources exclusively from Fresenius Kabi Oncology Limited, a related entity within the Fresenius Kabi group.
The company imports various Oxaliplatin formulations, including Oxaliplatin Kabi Inj. 200mg/40ml Vial and Oxitan Oxaliplatin Inj 150mg/30ml Vial. With an average shipment value of $27.7K, Fresenius Kabi Deutschland maintains a consistent and substantial procurement volume.
Other Major Buyers
Pharmacie Centrale des Hopitaux (Algeria) ranks as the third-largest importer, with $2.3 million in Oxaliplatin imports across 61 shipments. This Algerian government pharmacy procurement agency sources Xylatin 100 and Xylatin 50 formulations, serving the public healthcare system.
Yusen Logistics Benelux Belgium occupies the fourth position with $2.2 million in imports across 94 shipments. As a logistics and distribution company, Yusen handles Oxaliplatin Inj 100mg/20ml formulations for distribution across European markets.
OOO “JODAS EXPOIM” (Russia) appears twice among the top five buyers, with combined imports exceeding $4.1 million, highlighting the significant Russian demand for Oxaliplatin. India exported $6.5 million worth of Oxaliplatin to Russia through nine verified buyers.
Regional Analysis of Oxaliplatin Buyers
European Buyers
Europe represents a major market for Oxaliplatin procurement. Beyond Fresenius Kabi Deutschland, notable European importers include:
- Yusen Logistics Benelux Belgium — $2.2M
- Fresenius Kabi entities across multiple European countries — including operations in Germany, Belgium, and the UK
The European buyer landscape is characterized by large pharmaceutical distributors and multinational corporate procurement networks.
North American Buyers
The United States market for Oxaliplatin is served by 23 verified buyers importing from India, with total imports of $4.0 million. Key US buyers include:
- Meitheal Pharmaceuticals
- Mylan Institutional Inc.
- Fosun Pharma USA Inc
US buyers primarily source finished formulations, with the drug reimbursed under HCPCS J Code J9263.
Asian Buyers
Asian markets demonstrate growing demand for Oxaliplatin:
- Fresenius Kabi Malaysia Sdn Bhd — Ranks #11 globally with $696.5K in imports, 23 shipments
- Fresenius Kabi (Thailand) Ltd — $650.0K in imports
- C M C L (Thailand) — $620.1K in imports, ranking #14
Latin American Buyers
Latin American markets show significant procurement activity, with Peru, El Salvador, and Colombia emerging as key destinations. Fresenius Kabi Colombia SAS ranks #9 globally with $782.8K in imports.
African and Middle Eastern Buyers
Algeria’s Pharmacie Centrale des Hopitaux leads African procurement. Additional buyers in Jordan, Nigeria, and other African nations contribute to the diversified global buyer base.
Key Suppliers Serving Global Buyers
Understanding the supplier landscape is essential for buyers seeking reliable sourcing partners. Major Oxaliplatin manufacturers and suppliers include:
Global Pharmaceutical Manufacturers
- Sanofi-Aventis — Original innovator
- Fresenius Kabi — Major producer with oncology facilities in India
- Dr. Reddy’s Laboratories (India) — API and finished formulations
- Sun Pharmaceutical Industries (India) — API and finished products
- Teva Pharmaceutical Industries (Israel) — Generic formulations
- Hospira (Pfizer company) — US-based manufacturer
- Cipla (India) — API and finished formulations
- Mylan — Generic pharmaceutical producer
Leading Indian Exporters
India hosts 249 active Oxaliplatin exporters, with notable suppliers including:
- Fresenius Kabi Oncology Limited — Primary supplier to Fresenius Kabi global network
- Celon Laboratories Private Limited — $558.4K exports to 14 countries, ranking #14 among exporters
- Qilu Pharmaceutical — ANDA holder for Oxaliplatin formulations
- Jiangsu Hengrui Medicine — Major Chinese manufacturer
Celon Laboratories exports to 21 buyers globally, with its largest customer being Seven Pharma S.A.C (Peru) at $204.1K, followed by Seven Pharma El Salvador SA de C.V ($79.2K).
Oxaliplatin Formulations and Specifications
Buyers typically source Oxaliplatin in the following formulations:
| Formulation | Packaging | Common Applications |
|---|---|---|
| Oxaliplatin Inj 50mg/10ml | Single-dose vial | Colorectal cancer treatment |
| Oxaliplatin Inj 100mg/20ml | Single-dose vial | Colorectal, gastric cancers |
| Oxaliplatin Inj 200mg/40ml | Single-dose vial | High-dose protocols |
| Oxaliplatin concentrate for solution | Various | Hospital compounding |
Products are commonly marketed under brand names including Oxitan, Xylatin, and various generic equivalents.
How to Identify and Verify Oxaliplatin Buyers
For pharmaceutical companies, distributors, and exporters seeking to expand their Oxaliplatin customer base, the following strategies are recommended:
Utilize Trade Data Platforms
Platforms like Volza and Transdata Nexus provide verified customs data with buyer names, shipment volumes, and contact information. These platforms aggregate data from 90+ countries with mirror data from 119+ countries.
Leverage HSN Code Tracking
Oxaliplatin imports and exports are primarily tracked under HSN Code 30049049, with 235 buyers documented under this classification. Monitoring shipments under this code helps identify active buyers and emerging markets.
Monitor Regulatory Filings
DrugPatentWatch and PharmaDB provide information on manufacturers with active US DMFs and CEPs, indicating regulatory-compliant suppliers.
Attend Pharmaceutical Trade Events
Events such as IPHEX (International Exhibition for Pharma and Healthcare) provide networking opportunities with buyers and suppliers.
Market Trends and Future Outlook
Growing Market Demand
The Oxaliplatin market continues to expand, driven by:
- Rising global cancer incidence, particularly colorectal cancer
- Increasing generic drug penetration in emerging markets
- Expanding healthcare infrastructure in developing countries
The market is projected to grow from $1.12 billion in 2025 to $1.91 billion by 2031.
Shifting Procurement Patterns
Several trends are reshaping the Oxaliplatin buyer landscape:
- Consolidation of procurement through multinational pharmaceutical groups like Fresenius Kabi
- Growing Indian export dominance, with 249 active exporters serving 123 countries
- Emerging market expansion, particularly in Latin America, Africa, and Southeast Asia
- Increasing regulatory scrutiny, with buyers favoring WHO-GMP certified suppliers
Supply Chain Considerations
Buyers should evaluate suppliers based on:
- Regulatory compliance (US DMF, CEP, WHO-GMP certifications)
- Production capacity and reliability
- Pricing competitiveness
- Logistics and distribution capabilities
SEVEN PHARMA SAC
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORYPRIVATE LI
FRESENIUS KABI ONCOLOGY LIMITED
CÔNG TY TNHH SANOFI AVENTIS VIỆT NAM
PT IMCD INDONESIA
ULTRA INTERNATIONAL
SUN PHARMACEUTICAL INDUSTRIES LIMITED
GLOBO ASIATICO ENTERPRISES INC
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
INTAS PHARMACEUTICALS LIMITED
COMPA IA ASTOR S A
ATCO PHARMA INTERNATIONAL PRIVATE LIMITED
GYKORMED S A
VMG HEALTH CARE PRODUCTS S A
CEDIMED CIA LTDA
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED
CÔNG TY TNHH SANDOZ VIỆT NAM
M S ZAS CORPORATION
PERULAB SA
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
CHI NHÁNH CTY TNHH ZUELLIG PHARMA VIỆT NAM
M S HELIX PHARMA PVT LTD
RICONPHARMA INDIA PRIVATE LIMITED
EUGIA PHARMA SPECIALITIES LIMITED
FRESENIUS KABI CHILE LIMITADA
HIMMEL PHARMACEUTICALS PVT LTD
MYLAN INSTITUTIONAL INC
SAGENT PHARMACEUTICALS
SEVEN PHARMA COLOMBIA S A S
SIGMA ALDRICH QUIMICA S DE RL DE CV
ZETI PHARMACEUTICALS PHARMAZETI CIA LTDA
HEALTHCARE PHARMACEUTICALS LTD
HIMMEL PHARMACEUTICALS PVT LIMITED
KETAN PHARMA
NAIROBI ENTERPRISES LIMITED
QUINTILES CHILE
AL HABIB PHARMACEUTICALS
FRESENIUS KABI COLOMBIA SAS
2MG INCORPORATED
COMPANIA ASTOR S A
FOSUN PHARMA USA INC
LABORATORIO LKM S A
ANALYTICA CHEMIE INC
APOTEX INC
NOVAG INFANCIA SA DE CV
PFIZER INC
PHARMASTAR INTL TRADING CORPORATION
PT FONKO INTERNATIONAL PHARMACEUTICALS
UNITED STATES PHARMACOPEIA INDIA PRIVATE LIMITED
V M G HEALTHCARE PRODUCTS SOCIEDAD ANONIMA
BLAU FARMACEUTICA CHILE SPA
CÔNG TY CỔ PHẦN DƯỢC TRANG THIẾT BỊ Y TẾ BÌNH ĐỊNH BIDIPHAR
DIMERCO EXPRESS U S A CORP
DRUG INTERNATIONAL LIMITED
EVEREST PHARMACEUTICALS LIMITED
FRESENIUS KABI MEXICO SA DE CV
MERCK SHARP DOHME COMERCIALIZADORA S DE RL DE CV
PHARMASOL PRIVATE LTD
ACCORD FARMA SA DE CV
AMBICA INT L CORP
ESKAYEF PHARMACEUTICALS LIMITED
FUSA S A
LABORATORIO GADOR S A
LABORATORIO KEMEX SA
M S A J MIRZA PHARMA PVT LTD
MYLAN LABORATORIES LIMITED
PT KARUNIA MAKMUR SELARAS
SANDOZ SA DE CV
ТОО KELUN KAZPHARM КЕЛУН КАЗФАРМ
BEACON PHARMACEUTICALS PLC
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE LIMITED
LABORATORIOS VANQUISH SA DE CV
LAQFAGAL FARMA INDUSTRIA S R L
LAURUS LABS LIMITED
PHARMASTAR INTL TRADING CORP
RUSKIN CHEMIPHARM
SCHMIDTS PHARMA S R L
ACCORD HEALTHCARE LIMITED PHILIPPINE BRANCH OFFICE
CAREPHARMA INTERNATIONAL PVT LTD
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
ELCON DRUGS AND FORMULATIONS LIMITED
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
KHAIRI S A
LABORATORIO CHILE S A
LABORATORIOS EUROFARMA BOLIVIA SA
M S BF BIOSCIENCES LIMITED
M S KHAJA ENTERPRISE
NELPA LIFESCIENCES INC
ONCOLIFE CORP
ONCOLIFE CORPORATION
TEXAS CANCER CENTRE LIMITED
THERDOSE PHARMA PRIVATE LIMITED
VENUS REMEDIES LIMITED
VMG PHARMA S A
ООО BEST PHARM 995
CÔNG TY CỔ PHẦN KHOA HỌC CÔNG NGHỆ T T
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
DISTRIBUIDORA INTERNACIONAL MEDWELL SOCI
FONKO INTERNATIONAL PHARMACEUTICALS
FRESENIUS KABI PHILIPPINES INC
FTL PLUS INC
MULTICARE PHARMACEUTICALS
PT CKD OTTO PHARMACEUTICALS
SAKAR HEALTHCARE LIMITED
SANDOZ INC
SANOFI PASTEUR SA DE CV
SIGMA ALDRICH QUIMICA LIMITADA
SULE MENE SAGLIK ARASTIRMA EGITIM DANISMANLIK BILISIM SANAYI TICARET ANONIM SIRKETI
YOUBELIEVE PHARMA S A S
AL PHARMA SA
ALLIANZ BIOINNOVATION
AMAROX PHARMA SA DE CV
AUROVIDA FARMACEUTICA SA DE CV
CELNOVA ARGENTINA S A
CONEPRE SA DE CV
DISTRIBUIDORA INTERNACIONAL MEDWELL SOCIEDAD ANONIMA
FRESENIUS KABI CANADA
GENERICS AFRICA LIMITED
GLENMARK GENERICS S A
GLOBAL MEDICAL LOGISTICS SOCIEDAD ANONIM
INSPIRE PHARMACEUTICALS LIMITED
IQVIA RDS PERU S R L
KIREI PHARMA PARAGUAY SA
LABS SERVIER DE COLOMBIA S A S
M S HAKIMSONS IMPEX PVT LTD
MEDMART PHARMA PVT LTD
MERCK SA
NORTHSTAR DISTRIBUTION CENTER 8912
OOO TEK GRUP SAGLIK HIZMETLERI
PHIL PHARMAWEALTH INC
PPD GLOBAL LIMITED MERKEZI INGILTERE TURKIYE ISTANBUL SUBESI
QUALIMED PHARMA INC
RENATA PLC CHANGED FROM RENATA
ROCHE MUSTAHZARLARI SANAYI ANONIM SIRKETI
SANDOZ INC C O EXEL INC
SEVEN PHARMA LIMITADA
SIMSON PHARMA LIMITED
SRI AMAN CORPORINDO
YUSEN LOGISTICS BENELUX BV
ТОО DPB NEW BRANDS
AMGEN BIOTECNOLOGICA S A S
BF BIOSCIENCES LIMITED
CAPLIN POINT LABORATORIES LIMITED
CÔNG TY TNHH KHOA HỌC HỢP NHẤT
CÔNG TY TNHH MTV NOVALAB
CÔNG TY TNHH ZUELLIG PHARMA VIỆT NAM
DIEMPEC CIA LTDA DISTRIBUIDORA FARMACEUTICA
EUROQUIMICA S A
FINSTAD INC
G P PHARM SA
GLAND PHARMA LIMITED
GLOBAL MEDICAL LOGISTICS SOCIEDAD ANONIMA
HOSPIRA INC PLEASANT PRAIRIE WHSE
IE MEDICA INC
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE L
KOCAK FARMA ILAC VE KIMYA SANAYI ANONIM SIRKETI
LAB DIAGNOSTIC SYSTEMS SMC PVT LIMITED
LABORATORIOS IMA S A I C
LC LOGISTICS SERVICES INC
LIBRA PARAGUAY SA
MARTIN DOW SPECIALITIES PRIVATE LIMITED
MEDETHIX INC
MERCK SHARP DOHME I A LLC
MERCK SHARP DOHME PERU S R L
NIL MASKED
NUTRI MED SOCIEDAD ANONIMA
PHARMASOL PVT LTD
PSM PHARMACEUTICALS LIMITED
ROEMMERS SACI
SUNPAR PHARMACEUTICALS LIMITED
SYNGENE INTERNATIONAL LIMITED UNIT VII POD 3
TOKYO CHEMICAL INDUSTRY INDIA PRIVATE LIMITED
UGANDA CANCER INSTITUTE
ООО ALINFARM MEDICAL
101 SUPPLY CHAIN SOLUTIONS INC
ABBVIE FARMACEUTICOS SA DE CV
ABBVIE PROD FARMACEUTICOS LTDA
AGB PHARMACEUTICAL TRADING AND
AJ MIRZA PHARMA PVT LTD
AMBICA INTERNATIONAL CORPORATION
APOLLOPLUS CAPITAL INC
ARAGEN LIFE SCIENCES LIMITED
ASTOR ALLIANCE
BIO TECH PHARMA SOCIEDAD ANONIMA
BIOGENE INDIA
BIOMEDICAL LIFE SCIENCES
BLISS PHARMA DISTRIBUTION CONSUTRUCTION
BOLLORE LOGISTICS CANADA INC
BUGANDO MEDICAL CENTRE
CEVA AIR OCEAN CANADA INC
CORPORACION MAGMA ECUADOR S A
DHL GLOBAL FORWARDING
DHL GLOBAL FORWARDING 11601 WEST
DIMERCO EXPRESS USA CORP
DISTRIBUIDORA INTERNACIONAL MEDWELL SA
ERIOCHEM S A
EXPEDITORS INTERNATIONAL OF WA INC
EXPEDITORS INTERNATIONAL OF WASHING
FARMACEUTICA XENIUS LTDA
FARMACO URUGUAYO SA
GLAND PHARMA LIMITEDUNIT 2
GLOBAL MED FARMA S A C
HARLEYS LTD
HOSPIRA INC PLEASANT PRAIRIE WHSE CO
HURSHIDA ENTER DELUX
IMPORTADORA MAE LABS SA DE CV
JODAS EXPOIM PRIVATE LIMITED
KRISHNA CHEMISTS LIMITED
LANDULAMED WHOLESALERS DISTRIBUTORS CC NBOX30066 WINDHOEK NAMIBIA N44 KENN
LLC ASTOR ALLIANCE
MEDICINE SA
NATIONAL PHARMACY LIMITED
NORTHSTAR DISTRIBUTION CENTER
OLABAANI PHARMACEUTICALS LIMITED
ONCOPHARM U LTD
PHARMA INFOTECH INTERNATIONAL
PHILLIPS THERAPEUTICS LIMITED
PPD INTERNATIONAL HOLDINGS INC
ROYAL MEDICAL PRIVATE LIMITED
SAE GLOBAL LOGISTICS PAKISTAN PVT LTD
SAI PHARMACEUTICALS KENYA LIMITED
SCORP MEDITECH LIMITED
STATE PHARMACEUTICALS CORPORARION
SYNEOS HEALTH PERU S R L
SYNGENE INTERNATIONAL LIMITED
TEYRO LABS PRIVATE LIMITED
VEM ILAC SANAYI VE TICARET ANONIM SIRKETI
VMG PHARMA SOCIEDAD ANONIMA
ООО CHEMO LAB
ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ ХІМЛАБОРРЕАКТИВ М КИЇВ 03150 М КИЇВ ВУЛ ВЕЛИКА ВАСИЛЬКІВСЬКА 57 3
ТОО WEDEL PHARMA
A J MIRZA PHARMA PVT LIMITED
ADVANCED CHEMICAL INDUSTRIES LTD
AE ALCHEMISTS INC
ALFAGEN LABORATUVAR MALZEMELERI IC VE DIS TICARET SANAYI LIMITED SIRKETI
ARISTOPHARMA LTD CHANGE FROM
AZELIS TR KIMYA ENDUSTRISI URUNLERI ITHALAT IHRACAT TICARET VE SANAYI ANONIM SIRKETI
BIOCORNER INC
BIOETHIC PHARMA SOCIEDAD ANONIMA
BIONIFY BIOSCIENCE OPC PRIVATE LIMITED
BLAU FARMACEUTICA COLOMBIA SAS
BOLIVIAN TRACTOR LTDA
BOLLORE LOGISTICS CANADA INC 90
BRUZZONE SHIPPING INC
CARE PHARMA INTERNATIONAL PVT LIMITED
CEVA AIR OCEAN CANADA INC 90
CINCHONA BIOSCIENCES
COFOODS INC
CYGEN LABS LTDA
CÔNG TY CỔ PHẦN KỸ THUẬT VÀ SINH HỌC ỨNG DỤNG VIỆT NAM
CÔNG TY TNHH CÔNG NGHỆ TNT VIỆT NAM
CÔNG TY TNHH THƯƠNG MẠI H B C
DHL EXPRESS MEXICO SA DE CV
DHL GLOBAL FORWARDING 11601 WEST NY DHL GLOBAL FORWARDING 11601 WEST
DR REDDY S LABORATORIES LTD
EL ALAMO SA
ELECTRO CRAFTS
ELECTROCRAFTS
ENDURE MEDICAL INC
EVERON LIFE SCIENCES
FARMACEUTICA PARAGUAYA SA
FARMEDICAL S R L
FISHER CLINICAL SERVICES MEXICO S DE RL DE CV
GEKA PHARMA PTY LTD
GLAND PHARMA LTD
GLENMARK PHARMACEUTICALS KENYA LIMITED
GOLD TREE PHARMACEUTICALS LTD
GOODFELLOW PHARMA CORP
HAKIMSONS IMPEX PVT LTD
HELLMANN WORLDWIDE LOGISTICS AS
IBODULLAEVA MUKHAYYO BAKHROMOVNA
INTAS PHARMACEUTICALS LTD
JUNTA DE BENEFICENCIA DE GUAYAQUIL
KERRY EAS LOGISTICS LIMITED HAINAN BRANCH
KUEHNE NAGEL SP Z O O
LAB DIGNOSTIC SYSTEMS SMC PVT LTD
LABORATORIO LIBRA S A
LEISA ONCO CENTER SOCIEDAD ANONIMA
LIFE TECHNOLOGIES INDIA PRIVATE LIMITED
LLP MS STOCK
LOGÍSTICA E IMPORTACIONES ADUVIRI SRL
LUCKY DEVELOPMENT CORP PHARMACY 4
M S ROTEX PHARMA PVT LIMITED
MEDICAL SUPPLIES DIVISION
MERCK LIFE SCIENCE PRIVATE LIMITED
MERCK SHARP AND DOHME COLOMBIA S A S
MICROGENETIX INC
MINISTRY OF HEALTH OF GHANA
MIRZA PHARMA PVT LTD
MISSION FOR ESSENTIAL DRUGS AND SUPPLIES MEDS
NOVAGENTEK LABORATUAR URUNLERI VE TEKNOLOJILERI SANAYI VE TICARET ANONIM SIRKETI
NOVECY PHARMACY CC NP O BOX
NOVOPHARMA LIMITADA
OPSONIN PHARMA LIMITED
ORBIT CORPORATION
PAREXEL INTERNATIONAL PERU S A
PHARMAFFILIATES PRIVATE LIMITED
PHARMANANDA IC VE DIS TICARET ANONIM SIRKETI
PHARMARAW BANGLADESH PRB
PRINCE SCIENTIFIC
PT GLOBAL CHEMINDO MEGATRADING
PT MULTI EKA CHEMICALINDO
QUIMFA S A
RENATA LTD CHANGE FROM PFIZER
ROTEX PHARMA PVT LTD
SABIHA RESEARCH AND DEVELOPMENT LLP
SALIX PHARMA LIMITED
SEVEN PHARMA NICARAGUA SOCIEDAD A
SEVEN PHARMA PANAMA
SYNGENE INTERNATIONAL LTD
TASSOS S A
VALIANT PHARMACY CC
WORLDWIDE HEALTHCARE LIMITED
YUSEN LOGISTICS BENELUX BELGIUM
ДЕРЖАВНЕ ПІДПРИЄМСТВО МЕДИЧНІ ЗАКУПІВЛІ УКРАЇНИ 01601 М КИЇВ ВУЛ ГРУШЕВСЬКОГО 7
ПРЕД ВО SANDOZ PHARMACEUTICALS В РУ
ТОВ БУСТ ФАРМА 03022 КИЇВ В ВАСИЛЬКІВСЬКА Б 30
ТОВ ХІМЛАБОРРЕАКТИВ УКРАЇНА 03150 МІСТО КИЇВ ВУЛ ВЕЛИКА ВАСИЛЬКІВСЬКА БУДИНОК 57 3
Conclusion
The Oxaliplatin global buyers list reflects a dynamic and growing market for this essential oncology drug. With 693 active buyers across 123 countries and a market value exceeding $1 billion annually, opportunities abound for pharmaceutical manufacturers, exporters, and distributors.
Fresenius Kabi Deutschland GmbH leads global procurement with a 21.5% market share, followed by Russian, Algerian, and Belgian buyers. The supplier landscape is equally diverse, with Indian manufacturers dominating exports and global pharmaceutical giants maintaining significant production capabilities.
For stakeholders seeking to enter or expand in the Oxaliplatin market, understanding the buyer landscape, leveraging trade data platforms, and maintaining regulatory compliance are essential strategies for success. As the global cancer burden continues to rise, the demand for this vital chemotherapy agent will only intensify, making the Oxaliplatin global buyers list an increasingly valuable resource for the pharmaceutical industry.
